13 September 2024
You are about to leave the Clinical Value website now.
Cancel
Continue
Precision Oncology
Empowering Precision Oncology: Leveraging digital solutions to facilitate molecular tumour board meetings…
Read Article
The impact of the multi-disciplinary molecular tumour board and integrative next generation…
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was…
Read Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board…
These recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
Read Article
Breaking barriers to precision oncology implementation with digital solutions
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of standardization. The use of…
Read ArticleEmpowering Precision Oncology: Leveraging digital solutions to facilitate molecular tumour…
The impact of the multi-disciplinary molecular tumour board and integrative…
Recommendations for the Use of Next-Generation Sequencing and the Molecular…
Breaking barriers to precision oncology implementation with digital solutions
Globally, cancer is the leading cause of death, accounting for nearly 1 in 6 deaths in 2020 with majority coming from Asia. Given today’s ageing population, and emerging factors like diet and environment, the burden of cancer is only projected to increase.
To tackle the rising cancer burden and increase the chances of survival, the integration of diagnostic testing and treatment is key. In the era of precision oncology, genomic profiling, clinical decision support solutions, and multidisciplinary partnership can enable early diagnosis and personalised treatment, presenting the opportunity to improve the lives of millions of people around the world.
Expert Opinions
23 August 2023
NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff
In this article, Prof Peter Gibbs and Prof Svetlana Cherepanoff discuss the issues surrounding the clinical integration of NGS in Australia.
READ MORE
23 August 2023
NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh
NGS and digital applications for oncology management can help improve early cancer detection and prevention, reducing human and economic costs of the cancer. In this article,…
READ MORE
18 August 2023
NGS and precision oncology in India: insights from Dr Amit Rauthan
In this article, Dr Amit Rauthan shares insights on the challenges and opportunities for greater NGS adoption in India.
READ MORE
22 May 2023
NGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung
In this article, Dr Lam Tai-Chung shares how his institution has had first-hand experience of landmark cases and outstanding treatment responses from using NGS in seemingly…
READ MORE
22 May 2023
Next-generation sequencing (NGS) drives precision oncology in Singapore
In this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root.
READ MORE
22 May 2023
NGS and precision oncology in South Korea: insights from Prof Kim Jee-Hyun
In this article, Prof Jee Hyun Kim explains her clinical experiences of NGS, and how she sees it evolving within South Korea’s innovative healthcare ecosystem.
READ MORE
22 May 2023
Breaking barriers to precision oncology implementation with digital solutions
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of…
READ MOREKey Publications
17 August 2023
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
This study proposes a unified framework to classify targets for precision cancer medicine based on clinical evidence of utility, to aid oncologists in prioritising potential targets…
READ MORE
11 August 2023
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular…
READ MORE
19 May 2023
Unlocking the Value of Quality Next-Generation Sequencing in APAC
This whitepaper shares recommendations on ensuring standardization and quality of NGS across the region, to realize the potential of NGS and establish more effective and market-appropriate…
READ MORE19 May 2023
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
These recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
READ MORE
9 December 2022
APACMed White Paper – Strengthening Healthcare Systems Through the Critical Role of Diagnostics
Diagnostic technologies are used across the entire patient journey of multiple disease states, and provide the tools to prevent, detect, and monitor the required interventions. Despite…
READ MOREWebinars and Symposiums
APAC Oncology Summit 2024 Webinar
APAC Oncology Summit 2023 Webinar
The right tools at the right time: Liquid Biopsy enters the clinic
The field of clinical oncology continues to see drastic advancements with non-invasive techniques, such as liquid biopsy being adopted for diagnosing and monitoring cancers in place…
READ MORE
Digital Tools to Drive NGS Clinical Application for the Future
The growing amount of clinical data available for each patient, clinicians need to manage massive genomic information, histological analysis tools, and clinical trials and publications. They…
READ MOREDisease Awareness
11 April 2024
Injection or Infusion? How biologic cancer medicines can be given
11 April 2024